Goldman Sachs Call 450 VRTX 20.09.../ DE000GG2SCX1 /
| 9/5/2024 10:48:56 AM | Chg.+0.16 | Bid8:14:42 PM | Ask8:14:42 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 2.94EUR | +5.76% | 2.01 Bid Size: 3,000 |
2.16 Ask Size: 3,000 |
Vertex Pharmaceutica... | 450.00 USD | 9/20/2024 | Call |
GlobeNewswire
8/5
Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update
GlobeNewswire
8/5
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire
7/9
Payscale Expands Data & Technology Resources, Powering Decision-Focused Compensation Management
GlobeNewswire
7/9
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
GlobeNewswire
6/28
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...
GlobeNewswire
6/10
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire
5/15
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/9
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire
5/8
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
5/8
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...
GlobeNewswire
5/7
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
4/30
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...
GlobeNewswire
4/27
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire
4/22
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
